More on CGEM
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $18.48 |
|
|||
| Open | $18.43 | ||||
| 52 Wk High | $0.19 | ||||
| 52 Wk Low | $0.03 | ||||
| Day High | $19.43 | ||||
| Day Low | $18.38 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 294,862 | ||||
- Form 4 Cullinan Therapeutics, For: Jun 16 Filed by: Rosenberg Anthony
- Form 4 Cullinan Therapeutics, For: Jun 16 Filed by: Meek David D.
- Form 4 Cullinan Therapeutics, For: Jun 16 Filed by: Allen Andrew R
- Form 4 Cullinan Therapeutics, For: Jun 16 Filed by: Webster Stephen W
- Form 4 Cullinan Therapeutics, For: Jun 16 Filed by: Thistle Mary
- Form 4 Cullinan Therapeutics, For: Jun 16 Filed by: Doyle Mittie
- William Blair on Cullinan Oncology Inc. (CGEM): 'We continue to see multiple opportunities for upside to Cullinan shares'
- Cullinan Oncology Inc. (CGEM) PT Raised to $46 at Clear Street
- Cullinan Therapeutics reports clinical trial data for autoimmune treatments
- Cullinan Therapeutics Shares New Clinical Data Across Its Portfolio of T Cell Engager Programs Targeting CD19 and BCMA in Autoimmune Diseases
Entities mentioned with CGEM
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- 13G | View Related Stories »
- H.C. Wainwright | View Related Stories »
- Show More...
